Literature DB >> 28633864

Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies.

Jay Vornhagen1, Kristina M Adams Waldorf2, Lakshmi Rajagopal3.   

Abstract

Group B streptococcus (GBS) or Streptococcus agalactiae is a β-hemolytic, Gram-positive bacterium that is a leading cause of neonatal infections. GBS commonly colonizes the lower gastrointestinal and genital tracts and, during pregnancy, neonates are at risk of infection. Although intrapartum antibiotic prophylaxis during labor and delivery has decreased the incidence of early-onset neonatal infection, these measures do not prevent ascending infection that can occur earlier in pregnancy leading to preterm births, stillbirths, or late-onset neonatal infections. Prevention of GBS infection in pregnancy is complex and is likely influenced by multiple factors, including pathogenicity, host factors, vaginal microbiome, false-negative screening, and/or changes in antibiotic resistance. A deeper understanding of the mechanisms of GBS infections during pregnancy will facilitate the development of novel therapeutics and vaccines. Here, we summarize and discuss important advancements in our understanding of GBS vaginal colonization, ascending infection, and preterm birth.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Group B streptococcus; ascending infection; perinatal; preterm birth; vaginal colonization infection

Mesh:

Substances:

Year:  2017        PMID: 28633864      PMCID: PMC5650539          DOI: 10.1016/j.tim.2017.05.013

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  133 in total

1.  Identification of a glycosaminoglycan binding region of the alpha C protein that mediates entry of group B Streptococci into host cells.

Authors:  Miriam J Baron; David J Filman; Gina A Prophete; James M Hogle; Lawrence C Madoff
Journal:  J Biol Chem       Date:  2007-01-26       Impact factor: 5.157

2.  CsrRS regulates group B Streptococcus virulence gene expression in response to environmental pH: a new perspective on vaccine development.

Authors:  Isabella Santi; Renata Grifantini; Sheng-Mei Jiang; Cecilia Brettoni; Guido Grandi; Michael R Wessels; Marco Soriani
Journal:  J Bacteriol       Date:  2009-06-19       Impact factor: 3.490

3.  The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.

Authors:  Monica Fabbrini; Fabio Rigat; C Daniela Rinaudo; Irene Passalaqua; Sceida Khacheh; Roberta Creti; Lucilla Baldassarri; Filippo Carboni; Giulia Anderloni; Roberto Rosini; Domenico Maione; Guido Grandi; John L Telford; Immaculada Margarit
Journal:  Clin Infect Dis       Date:  2016-07-11       Impact factor: 9.079

Review 4.  Preterm labor: one syndrome, many causes.

Authors:  Roberto Romero; Sudhansu K Dey; Susan J Fisher
Journal:  Science       Date:  2014-08-14       Impact factor: 47.728

5.  Maternal carriage and neonatal acquisition of group B streptococci.

Authors:  J A Hoogkamp-Korstanje; L J Gerards; B P Cats
Journal:  J Infect Dis       Date:  1982-06       Impact factor: 5.226

6.  Acidic pH strongly enhances in vitro biofilm formation by a subset of hypervirulent ST-17 Streptococcus agalactiae strains.

Authors:  Nunzia D'Urzo; Manuele Martinelli; Alfredo Pezzicoli; Virginia De Cesare; Vittoria Pinto; Immaculada Margarit; John Laird Telford; Domenico Maione
Journal:  Appl Environ Microbiol       Date:  2014-01-31       Impact factor: 4.792

7.  Choriodecidual Group B Streptococcal Infection Induces miR-155-5p in the Fetal Lung in Macaca nemestrina.

Authors:  Ryan M McAdams; Craig J Bierle; Erica Boldenow; Samantha Weed; Jesse Tsai; Richard P Beyer; James W MacDonald; Theo K Bammler; H Denny Liggitt; Federico M Farin; Jeroen Vanderhoeven; Lakshmi Rajagopal; Kristina M Adams Waldorf
Journal:  Infect Immun       Date:  2015-07-20       Impact factor: 3.441

8.  Group B Streptococcus β-hemolysin/cytolysin breaches maternal-fetal barriers to cause preterm birth and intrauterine fetal demise in vivo.

Authors:  Tara M Randis; Shari E Gelber; Thomas A Hooven; Rosanna G Abellar; Leor H Akabas; Emma L Lewis; Lindsay B Walker; Leah M Byland; Victor Nizet; Adam J Ratner
Journal:  J Infect Dis       Date:  2014-01-28       Impact factor: 5.226

9.  Binding of human IgA to HCl-extracted c protein from group B streptococci (GBS).

Authors:  A I Kvam; O J Iversen; L Bevanger
Journal:  APMIS       Date:  1992-12       Impact factor: 3.205

Review 10.  An overview of global GBS epidemiology.

Authors:  Kirsty Le Doare; Paul T Heath
Journal:  Vaccine       Date:  2013-08-28       Impact factor: 3.641

View more
  38 in total

1.  Group B streptococcus exploits vaginal epithelial exfoliation for ascending infection.

Authors:  Jay Vornhagen; Blair Armistead; Verónica Santana-Ufret; Claire Gendrin; Sean Merillat; Michelle Coleman; Phoenicia Quach; Erica Boldenow; Varchita Alishetti; Christina Leonhard-Melief; Lisa Y Ngo; Christopher Whidbey; Kelly S Doran; Chad Curtis; Kristina M Adams Waldorf; Elizabeth Nance; Lakshmi Rajagopal
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

2.  Human Cervical Mucus Plugs Exhibit Insufficiencies in Antimicrobial Activity Towards Group B Streptococcus.

Authors:  Jay Vornhagen; Phoenicia Quach; Verónica Santana-Ufret; Varchita Alishetti; Alyssa Brokaw; Blair Armistead; Hai Qing Tang; James W MacDonald; Theo K Bammler; Kristina M Adams Waldorf; Niels Uldbjerg; Lakshmi Rajagopal
Journal:  J Infect Dis       Date:  2018-04-23       Impact factor: 5.226

3.  Mast cell chymase decreases the severity of group B Streptococcus infections.

Authors:  Claire Gendrin; Nicholas J Shubin; Erica Boldenow; Sean Merillat; Morgan Clauson; Danial Power; Kelly S Doran; Magnus Abrink; Gunnar Pejler; Lakshmi Rajagopal; Adrian M Piliponsky
Journal:  J Allergy Clin Immunol       Date:  2017-09-12       Impact factor: 10.793

Review 4.  Cervical hyaluronan biology in pregnancy, parturition and preterm birth.

Authors:  Mala Mahendroo
Journal:  Matrix Biol       Date:  2018-03-03       Impact factor: 11.583

Review 5.  Streptococcus agalactiae in pregnant women in Brazil: prevalence, serotypes, and antibiotic resistance.

Authors:  Cilicia S do Nascimento; Nayara F B Dos Santos; Rita C C Ferreira; Carla R Taddei
Journal:  Braz J Microbiol       Date:  2019-08-20       Impact factor: 2.476

6.  Modulation of Death and Inflammatory Signaling in Decidual Stromal Cells following Exposure to Group B Streptococcus.

Authors:  Rebecca A Flaherty; Maja Magel; David M Aronoff; Jennifer A Gaddy; Margaret G Petroff; Shannon D Manning
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

7.  Genome-Wide Assessment of Streptococcus agalactiae Genes Required for Survival in Human Whole Blood and Plasma.

Authors:  Luchang Zhu; Prasanti Yerramilli; Layne Pruitt; Matthew Ojeda Saavedra; Concepcion C Cantu; Randall J Olsen; Stephen B Beres; Andrew S Waller; James M Musser
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

8.  Protein kinase D mediates inflammatory responses of human placental macrophages to Group B Streptococcus.

Authors:  Jessica A Sutton; Lisa M Rogers; Beverly R E A Dixon; Leslie Kirk; Ryan Doster; Holly M Algood; Jennifer A Gaddy; Rebecca Flaherty; Shannon D Manning; David M Aronoff
Journal:  Am J Reprod Immunol       Date:  2019-01-30       Impact factor: 3.886

9.  Diagnostic Performance of Various Methodologies for Group B Streptococcus Screening in Pregnant Woman in China.

Authors:  Kankan Gao; Qiulian Deng; Lianfen Huang; Chien-Yi Chang; Huamin Zhong; Yongqiang Xie; Xiaoshan Guan; Haiying Liu
Journal:  Front Cell Infect Microbiol       Date:  2021-05-24       Impact factor: 5.293

10.  Deviations in the gut microbiota of neonates affected by maternal group B Streptococcus colonization.

Authors:  Yue-Feng Li; Xue-Lei Gong; Su-Xiang Chen; Kejian Wang; Yan-Hua Jiang
Journal:  BMC Microbiol       Date:  2021-05-05       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.